is it illegal to compound semaglutide FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products Medscape | Novo Nordisk has

GLP-1s may help by promoting weight loss and reducing inflammation

Continuous GLP-1 exposure triggers changes in insulin sensitivity and blood sugar regulation

For bulk orders and academic pricing, contact our team.

Tackling emotional triggers, stress, and mood can enhance long-term results

It enhances slow-wave sleep without causing sedation, distinguishing it from drugs like Ambien or benzodiazepines

Researchers are studying how they impact a range of different health issues including (but not limited to): Sleep apnea Metabolic disorders Neurodegenerative disorders Substance use disorders Liver disease Arthritis Inflammatory bowel disease Completing research studies and gaining FDA approval for new use cases takes time, but it looks likely that GLP-1s could be prescribed as treatment for a growing list of health issues in the coming years